This Standard and Guidance, a collaboration between MAPS, PhactMI, MILE, is intended to inform learners about the Medical Information (MI) function, strategic direction, and operations across multiple geographies.
This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.
This webinar serves as guidance for how to overcome barriers to access patients compliantly.
This presentation, part 3 of 3, provides insights into the types of communications that the FDA has indicated are or are not permissible, and the uncertainties that still remain.
By using the framework of Explore, Educate, Embrace we can shape our approach to Health Equity by incorporating it into our daily work.
This webinar program will focus on the innovative applications of internal performance management platforms such as the Medical Productivity Index (MPI) and external events, namely the 2022 Medical Affairs Innovation Olympics in pharma that illustrate examples of more continuous, real time feedback on performance, new data science analytics driven analysis of performance, more even distribution of accountability, and increased resources to accelerate learning and development.
ChatGPT is disrupting content creation, from term papers to journal articles to online information mills and more. This webinar gathers three thought leaders at the cutting edge of this issue to vision how ChatGPT may augment or, at times, undermine the practice of Medical Affairs in areas such as Medical Information, Omnichannel engagement and more.
In today’s episode, we speak with Chris Medieros about how to maximize your organization’s presence and impact at congresses.
In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future.